The NIH reports that 70% of medicines given to children have only been studied in adults; therefore, most drugs used to treat diseases in children are used off-label — without an adequate understanding of the appropriate dose, safety, or efficacy. Off-label prescribing has become the treatment of choice because of the lack of clinical trials in the pediatric population.
Explore related content and topics
Blog
Search for a Cure: Type 1 Diabetes
Read Story
Blog
Improving Trial Participation for Families Through Decentralized Clinical Trials
As understanding advances and precedents are established for DCT-focused development programs, all stakeholders in clinical research will benefit…
Read Story
Page
Brandon Early, Vice President for Project Delivery
We measure our HQ with actions, experiences, and intentions. Nowhere is that more evident that in the stories of our subject matter experts. We want…
Read More
View all related content and resources for Pediatrics
Explore Insights